Combined Photosensitive Gene Therapy Effective Against Triple-Negative Breast Cancer in Mice Model

References

• Singh H. Role of molecular targeted therapeutic drugs in treatment of breast cancer: a review article. Glob Med Genet. 2023;10(02):79–86. doi:10.1055/s-0043-57247
   PubMedGoogle Scholar
• Dawson SJ, Provenzano E, Caldas C. Triple negative breast cancers: clinical and prognostic implications. Eur J Cancer. 2009;45(1):27–40. doi:10.1016/s0959-8049(09)70013-9
   PubMedGoogle Scholar
• Lebert JM, Lester R, Powell E, Seal M, McCarthy J. Advances in the systemic treatment of triple-negative breast cancer. Curr Oncol. 2018;25(11):142–150. doi:10.3747/co.25.3954
   Google Scholar
• Witzel I, Oliveira-Ferrer L, Pantel K, Müller V, Wikman H. Breast cancer brain metastases: biology and new clinical perspectives. Breast Cancer Res. 2016;18(1):8. doi:10.1186/s13058-015-0665-1
   PubMed Web of Science ®Google Scholar
• Gobbini E, Ezzalfani M, Dieras V, et al. Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort. Eur J Cancer. 2018;96:17–24. doi:10.1016/j.ejca.2018.03.015
   PubMed Web of Science ®Google Scholar
• Abramson VG, Lehmann BD, Ballinger TJ, Pietenpol JA. Subtyping of triple-negative breast cancer: implications for therapy. Cancer. 2015;121(1):8–16. doi:10.1002/cncr.28914
   PubMed Web of Science ®Google Scholar
• Dougherty TJ, Gomer CJ, Henderson BW, et al. Photodynamic therapy. J National Cancer Inst. 1998;90(12):889–905. doi:10.1093/jnci/90.12.889
   PubMed Web of Science ®Google Scholar
• Yu Y, Wang N, Wang YY, et al. Photodynamic therapy combined with systemic chemotherapy for unresectable extrahepatic cholangiocarcinoma: a systematic review and meta-analysis. Photodiagnosis Photodyn Ther. 2023:41. doi:10.1016/j.pdpdt.2023.103318.
   Web of Science ®Google Scholar
• Overchuk M, Weersink RA, Wilson BC, Zheng G. Photodynamic and photothermal therapies: synergy opportunities for nanomedicine. ACS Nano. 2023;17(9):7979–8003. doi:10.1021/acsnano.3c00891
   PubMed Web of Science ®Google Scholar
• Wufuer R, Ma HX, Luo MY, Xu KY, Kang L. Downregulation of Rac1/PAK1/LIMK1/cofilin signaling pathway in colon cancer SW620 cells treated with Chlorin e6 photodynamic therapy. Photodiagnosis Photodyn Ther. 2021;33. doi:10.1016/j.pdpdt.2020.102143
   Web of Science ®Google Scholar
• Lee J, Park HY, Kim WW, et al. Combination treatment with photodynamic therapy and laser ablation in breast cancer: an animal model study. Photomed Laser Surg. 2017;35(9):505–512. doi:10.1089/pho.2017.4291
   PubMed Web of Science ®Google Scholar
• Koukourakis MI, Giatromanolaki A, Skarlatos J, et al. Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy. Cancer Res. 2001;61(5):1830–1832.
   PubMed Web of Science ®Google Scholar
• Liu Y, Liu Y, Bu W, et al. Radiation-/hypoxia-induced solid tumor metastasis and regrowth inhibited by hypoxia-specific upconversion nanoradiosensitizer. Biomaterials. 2015;49:1–8. doi:10.1016/j.biomaterials.2015.01.028
   PubMed Web of Science ®Google Scholar
• Brown SB, Brown EA, Walker I. The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol. 2004;5(8):497–508. doi:10.1016/s1470-2045(04)01529-3
   PubMed Web of Science ®Google Scholar
• Petre PM, Baciewicz FA, Tigan S, Spears JR. Hyperbaric oxygen as a chemotherapy adjuvant in the treatment of metastatic lung tumors in a rat model. J Thorac Cardiovasc Surg. 2003;125(1):85–95. doi:10.1067/mtc.2003.90
   PubMed Web of Science ®Google Scholar
• Weaver LK, Hopkins RO, Chan KJ, et al. Hyperbaric oxygen for acute carbon monoxide poisoning. New Engl J Med. 2002;347(14):1057–1067. doi:10.1056/NEJMoa013121
   PubMed Web of Science ®Google Scholar
• Cheng Y, Cheng H, Jiang C, et al. Perfluorocarbon nanoparticles enhance reactive oxygen levels and tumour growth inhibition in photodynamic therapy. Nat Commun. 2015;6:8785. doi:10.1038/ncomms9785
   PubMed Web of Science ®Google Scholar
• Song G, Liang C, Yi X, et al. Perfluorocarbon-loaded Hollow Bi2Se3 nanoparticles for timely supply of oxygen under near-Infrared light to enhance the radiotherapy of cancer. Adv Mater. 2016;28(14):2716–2723. doi:10.1002/adma.201504617
   PubMed Web of Science ®Google Scholar
• Yin Z, Chen D, Zou J, et al. Tumor microenvironment responsive Oxygen-self-generating nanoplatform for dual-Imaging guided photodynamic and photothermal therapy. Chemistry Select. 2018;3(16):4366–4373. doi:10.1002/slct.201800498
   Google Scholar
• Yang X, Yang Y, Gao F, Wei JJ, Qian CG, Sun MJ. Biomimetic hybrid nanozymes with self-supplied H(+) and accelerated O(2) generation for enhanced starvation and photodynamic therapy against hypoxic tumors. Nano Lett. 2019;19(7):4334–4342. doi:10.1021/acs.nanolett.9b00934
   PubMed Web of Science ®Google Scholar
• Yu ZZ, Zhou P, Pan W, Li N, Tang B. A biomimetic nanoreactor for synergistic chemiexcited photodynamic therapy and starvation therapy against tumor metastasis. Nat Commun. 2018;9. doi:10.1038/s41467-018-07197-8
   PubMed Web of Science ®Google Scholar
• Zheng DW, Li B, Li CX, et al. Carbon-dot-decorated carbon nitride nanoparticles for enhanced photodynamic therapy against hypoxic tumor via water splitting. ACS Nano. 2016;10(9):8715–8722. doi:10.1021/acsnano.6b04156
   PubMed Web of Science ®Google Scholar
• Huang JQ, Zhao LP, Zhou X, et al. Carrier free O-2-economizer for photodynamic therapy against hypoxic tumor by inhibiting cell respiration. Small. 2022;18(15). doi:10.1002/smll.202107467
   Web of Science ®Google Scholar
• Chen HC, He CK, Chen TY, Xue XL. New strategy for precise cancer therapy: tumor-specific delivery of mitochondria-targeting photodynamic therapy agents and in situO(2)-generation in hypoxic tumors. Biomater Sci. 2020;8(14):3994–4002. doi:10.1039/d0bm00500b
   PubMed Web of Science ®Google Scholar
• Lv W, Zhang Z, Zhang KY, et al. A mitochondria-targeted photosensitizer showing improved photodynamic therapy effects under hypoxia. Angew Chem Int Edit. 2016;55(34):9947–9951. doi:10.1002/anie.201604130
   PubMed Web of Science ®Google Scholar
• Wang MM, Yang ZY, Song Y, et al. length Proteasomal and autophagy-mediated degradation of mutp53 proteins through mitochondria-targeting aggregation-induced-emission materials. Acta Biomater. 2022;150:402–412. doi:10.1016/j.actbio.2022.07.057
   PubMed Web of Science ®Google Scholar
• Wang YJ, Zheng JS, Lin J, Ye K, Wei P. Mitochondria-targeting and ROS-responsive nanocarriers via amphiphilic TPP-PEG-TK-Ce6 for nanoenabled photodynamic therapy. Adv Polym Technol. 2022. doi:10.1155/2022/1178039
   Web of Science ®Google Scholar
• Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell. 2011;147(2):275–292. doi:10.1016/j.cell.2011.09.024
   PubMed Web of Science ®Google Scholar
• Li XP, Zhao Y, Zhang T, Xing D. Mitochondria-specific agents for photodynamic cancer therapy: a key determinant to boost the efficacy. Adv Healthc Mater. 2021;10(3). doi:10.1002/adhm.202001240
   Web of Science ®Google Scholar
• Hammond SM. RNAi, microRNAs, and human disease. Cancer Chemother Pharmacol. 2006;58(1):s63–68. doi:10.1007/s00280-006-0318-2
   PubMedGoogle Scholar
• Gong Y, Liu W, Zhang N, He Y, Hong M, Dong J. Analysis of miR-34a expression and function in breast cancer tissues and cells. Cancer Res Prev Treatt. 2013;40(10):943–948. doi:10.3971/j.issn.1000-8578.2013.10.007
   Google Scholar
• Di Paolo D, Pastorino F, Brignole C, et al. Combined replenishment of miR-34a and let-7b by targeted nanoparticles inhibits tumor growth in neuroblastoma preclinical models. Small. 2020;16(20). doi:10.1002/smll.201906426
   PubMed Web of Science ®Google Scholar
• Ambros PF, Ambros IM, Brodeur GM, et al. International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee. Br J Cancer. 2009;100(9):1471–1482. doi:10.1038/sj.bjc.6605014
   PubMed Web of Science ®Google Scholar
• Deng X, Cao M, Zhang J, et al. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer. Biomaterials. 2014;35(14):4333–4344. doi:10.1016/j.biomaterials.2014.02.006
   PubMed Web of Science ®Google Scholar
• Trivedi M, Singh A, Talekar M, Pawar G, Shah P, Amiji M. MicroRNA-34a encapsulated in hyaluronic acid nanoparticles induces epigenetic changes with altered mitochondrial bioenergetics and apoptosis in non-small-cell lung cancer cells. Sci Rep. 2017;7. doi:10.1038/s41598-017-02816-8.
   Web of Science ®Google Scholar
• Shimanovich U, Volkov V, Eliaz D, Aizer A, Michaeli S, Gedanken A. Stabilizing RNA by the sonochemical formation of RNA nanospheres. Small. 2011;7(8):1068–1074. doi:10.1002/smll.201002238
   PubMed Web of Science ®Google Scholar
• Gandhi NS, Tekade RK, Chougule MB. Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances. J Control Release. 2014;194:238–256. doi:10.1016/j.jconrel.2014.09.001
   PubMed Web of Science ®Google Scholar
• Navarro G, Pan J, Torchilin VP. Micelle-like nanoparticles as carriers for DNA and siRNA. Mol Pharmaceut. 2015;12(2):301–313. doi:10.1021/mp5007213
   PubMed Web of Science ®Google Scholar
• Shi L, Wu W, Duan Y, et al. Light-induced self-escape of spherical nucleic acid from endo/lysosome for efficient non-cationic gene delivery. Angew Chem Int Ed Engl. 2020;59(43):19168–19174. doi:10.1002/anie.202006890
   PubMed Web of Science ®Google Scholar
• Yang YX, Ning HJ, Xia TP, et al. Electrostatic attractive self-delivery of siRNA and light-induced self-escape for synergistic gene therapy. Adv Mater. 2023;35(30). doi:10.1002/adma.202301409
   Web of Science ®Google Scholar
• Imani S, Zhang XQ, Hosseinifard H, Fu SY, Fu JJ. The diagnostic role of microRNA-34a in breast cancer: a systematic review and meta-analysis. Oncotarget. 2017;8(14):23177–23187. doi:10.18632/oncotarget.15520
   PubMedGoogle Scholar
• Kessel D. Subcellular targets for photodynamic therapy: implications for initiation of apoptosis and autophagy. J Natl Compr Cancer Netw. 2012;10:S56–S59. doi:10.6004/jnccn.2012.0177
   PubMed Web of Science ®Google Scholar
• Zhong XM, Li P, Li J, He RL, Cheng GC, Li YM. Downregulation of microRNA-34a inhibits oxidized low-density lipoprotein-induced apoptosis and oxidative stress in human umbilical vein endothelial cells. Int J Mol Med. 2018;42(2):1134–1144. doi:10.3892/ijmm.2018.3663
   PubMed Web of Science ®Google Scholar
• Maeda H, Yao HW, Rizal S, Teape D, Dennery P. Hyperoxic exposure increases microRNA-34a, leading to senescence in lung epithelial cells. Free Radic Biol Med. 2022;180:49–50. doi:10.1016/j.freeradbiomed.2021.12.108
   Web of Science ®Google Scholar